/Intravascular%20ultrasound%20imaging%20cardiac%20catheterization%20lab%20by%20Pitchy%20via%20Adobe%20Stock.jpeg)
IQVIA Holdings is set to announce its second-quarter earnings soon, and Wall Street expects a single-digit rise in its profits.
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
Despite underperforming its industry peers over the past year, analysts remain highly bullish on Charles River Laboratories' long-term prospects.
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Turn Down
Insights drawn from executive Summit hosted by Wiley and IQVIA with leaders from pharma, academia, health systems, technology companies and more
2 S&P 500 Stocks Worth Investigating and 1 Facing Headwinds
IQVIA Holdings has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.
Q1 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment